Aptima® HCV Quant Dx Assay

Confirmation of active HCV infection and monitoring HCV viral load on the fully automated Panther® system.  

Aptima® Herpes Simplex 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3

Aptima® Herpes Simplex 1 & 2 assay

NAATs, such as the Aptima® HSV 1 & 2 assay, are recommended by the CDC and WHO for HSV diagnosis. They are increasingly preferred over viral culture to diagnose genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.2,3 The Aptima HSV 1 & 2 assay distinguishes between HSV-1 and HSV-2 with significant reduction in hands-on time for laboratory professionals when compared to culture and other instrument platforms.

Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.
 
Aptima® HIV-1 Quant Dx Assay

Aptima® HIV-1 Quant Dx Assay

HIV-1 Detection and Viral Load Monitoring With performance you can count on, the Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management.1 It offers reliable quantitation of HIV-1 RNA across a broad linear range, giving your lab excellent precision and sensitivity for HIV-1 detection and viral load monitoring.

Aptima® HPV +ThinPrep® Cervical Health

Cervical disease screening is an essential component of our efforts in women’s health. Hologic is the leader in Pap and human papillomavirus (HPV) testing. The ThinPrep Pap test helps healthcare providers and laboratory professionals detect the presence of abnormal cervical cells, and the Aptima HPV assays identify high-risk HPV mRNA that is indicative of the HPV infections most likely to lead to cervical disease.1-3  

Know the Facts

The Pap test has been the most successful cancer screening program in history.4

The rate of cervical cancer, which was a leading cause of death among women, has fallen by more than 70 percent since the Pap test was introduced over 80 years ago.5 Previously, cervical cancer was the leading cause of cancer death in women, but now it is the fifteenth most frequent.

Reducing cervical cancer incidence requires a comprehensive strategy.

Such a strategy will include screening options that take into account disparities that underserved women face. This strategy should focus on reducing preventive screening gaps by:

  • Implementing provider and patient education
  • Providing access to vaccinations
  • Offering Pap + HPV (co-testing)

Aptima® Multitest Swab Specimen Collection Kit

With just one sample, the Aptima Multitest Swab simplifies testing and provides more answers for sexual and vaginal health.

Aptima® Mycoplasma genitalium Assay

Mycoplasma genitalium (M. gen) is an emerging health concern.
Testing for M. gen is recommended for all patients with recurrent urethritis, cervicitis and PID.1 Both women and men with M. gen infections are often asymptomatic and when left untreated, this infection can result in serious health consequences.

Aptima® STIs

STI testing for improved sexual health. The Aptima STI portfolio supports sexual health testing with a comprehensive, flexible menu of sexually transmitted infection (STI) assays.

   

Aptima® Trichomonas vaginalis assay

Trichomonas vaginalis (TV) is the most common curable STI in the United states.1 Over 3.7 million people in the United States have TV, which is a higher prevalence than chlamydia and gonorrhea infections combined.1 The CDC recommends testing women for TV infection if they are symptomatic or at increased risk of infection.2 The CDC and ACOG also recommend the use of a highly sensitive and specific test, such as the Aptima® Trichomonas vaginalis assay.2,3

Aptima® Vaginal Health

The Aptima vaginitis panel from Hologic consists of molecular nucleic acid amplification tests (NAAT) to aid in the detection of vaginosis and vaginitis. Our assays detect the three most common causes of infectious vaginitis: bacterial vaginosis, candida vaginitis and trichomoniasis.

Aptima® Vaginal Health

The Aptima vaginitis panel from Hologic consists of molecular nucleic acid amplification tests (NAAT) to aid in the detection of vaginosis and vaginitis. Our assays detect the three most common causes of infectious vaginitis: bacterial vaginosis, candida vaginitis and trichomoniasis.

Aptima® Virology

The Aptima Virology portfolio delivers on the Hologic promise of innovation through life-changing viral testing for viruses that impact patients across the globe.

Aquilex® Fluid Management System

Simple solutions for patient care. Designed to optimize high aspiration procedures such as the MyoSure® tissue removal procedure, the Aquilex fluid management system:

AriaTele patient-worn telemetry

Spacelabs’ AriaTele telemetry transmitter delivers a high performance product with a large full color screen. View your patient’s ECG or SpO2 waveforms from the large easy to read graphic display. Up to four leads of ECG, lead by lead, can be viewed along with the heart rate. Signal quality and battery level icons provide operational peace of mind. Powered by either standard AA alkaline or eco-conscious NiMH rechargeable batteries and waterproofed to IPX7, AriaTele provides both reliability and a cost effective means of monitoring your ambulatory patients.

Athena 500i

Loading...